Gastrointestinal stromal tumors: ESMO Clinical Recommendations for diagnosis, treatment and follow-up

被引：113

作者：

Casali, P. G.

Jost, L.

Reichardt, P.

Schlemmer, M.

Blay, J. -Y.

机构：

[1] ESMO Head Off, ESMO Guidelines Working Grp, CH-6962 Viganello Lugano, Switzerland

[2] Ist Nazl Tumori, Dept Canc Med, I-20133 Milan, Italy

[3] Kantonsspital, Dept Oncol, Bruderhotz, Switzerland

来源：

ANNALS OF ONCOLOGY | 2008年 / 19卷

关键词：

D O I：

10.1093/annonc/mdn080

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

[No abstract available]

引用

页码：35 / 38

页数：4

共 15 条

[1]

We should desist using RECIST, at least in GIST [J].

Benjamin, Robert S. ;

Choi, Haesun ;

Macapinlac, Homer A. ;

Burgess, Michael A. ;

Patel, Shreyaskumar R. ;

Chen, Lei L. ;

Podoloff, Donald A. ;

Charnsangavej, Chuslip .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1760-1764

[2]

Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].

Blanke, Charles D. ;

Rankin, Cathryn ;

Demetri, George D. ;

Ryan, Christopher W. ;

von Mehren, Margaret ;

Benjamin, Robert S. ;

Raymond, A. Kevin ;

Bramwell, Vivien H. C. ;

Baker, Laurence H. ;

Maki, Robert G. ;

Tanaka, Michael ;

Hecht, J. Randolph ;

Heinrich, Michael C. ;

Fletcher, Christopher D. M. ;

Crowley, John J. ;

Borden, Ernest C. .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632

[3]

Blay JY, 2007, J CLIN ONCOL, V25, P1107, DOI 10.1200/JCO.2006.09.0183

[4]

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours [J].

Debiec-Rychter, Maria ;

Sciot, Raf ;

Le Cesne, Axel ;

Schlemmer, Marcus ;

Hohenberger, Peter ;

van Oosterom, Allan T. ;

Blay, Jean-Yves ;

Leyvraz, Serge ;

Stul, Michel ;

Casali, Paolo G. ;

Zalcberg, John ;

Verweij, Jaap ;

Van Glabbeke, Martine ;

Hagemeijer, Anne ;

Judson, Ian .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1093-1103

[5]

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST) [J].

DeMatteo, Ronald P. ;

Gold, Jason S. ;

Saran, Lisa ;

Goenen, Mithat ;

Liau, Kui Hin ;

Maki, Robert G. ;

Singer, Samuel ;

Besmer, Peter ;

Brennan, Murray F. ;

Antonescu, Cristina R. .

CANCER, 2008, 112 (03) :608-615

[6]

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[7]

Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[8]

Diagnosis of gastrointestinal stromal tumors: A consensus approach [J].

Fletcher, CDM ;

Berman, JJ ;

Corless, C ;

Gorstein, F ;

Lasota, J ;

Longley, BJ ;

Miettinen, M ;

O'Leary, TJ ;

Remotti, H ;

Rubin, BP ;

Shmookler, B ;

Sobin, LH ;

Weiss, SW .

HUMAN PATHOLOGY, 2002, 33 (05) :459-465

[9]

Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466

[10]

Long-term outcomes of laparoscopic resection of gastric gastrointestinal stromal tumors [J].

Novitsky, Yuri W. ;

Kercher, Kent W. ;

Sing, Ronald F. ;

Heniford, B. Todd .

ANNALS OF SURGERY, 2006, 243 (06) :738-747

← 1 2 →